HIF1A and non-small cell lung carcinoma: Our finding that the metabolism of those resistant cells is specially programmed via ROS-induced HIF-1α underscores the idea that emergence of elevated ROS levels in NSCLC but not in SCLC is a key factor in metabolic adaption in response to drug-induced oxidative stress.